Cancer research saves lives and leads to improved outcomes for patients. But federal cancer research funding may be in jeopardy for 2026.

Study participants are enrolled in cohorts based on their tumor types (e.g., an advanced solid tumor), the genomic alterations of their tumors, and the targeted drug (s) matched to those alterations ...

The American Society of Clinical Oncology (ASCO) is a medical professional oncology society committed to conquering cancer through research, education, prevention, and delivery of high-quality patient ...

The Career Development Award (CDA) provides research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer re ...

This section provides key information on oncology events organized by ASCO or other organizations throughout the world. To submit an event, please fill out this form. Content on ASCO's Calendar of ...

Sacituzumab govitecan (SG) + pembrolizumab (pembro) vs chemotherapy (chemo) + pembro in previously untreated PD-L1–positive advanced triple-negative breast cancer (TNBC): Primary results from the ...

SPARGO, Inc. is the only official registration and housing provider for ASCO Meetings and Symposia. Individuals unaffiliated with ASCO or SPARGO, Inc. may entice prospective attendees into registering ...

Learn about the 2025 Conquer Cancer Grants & Awards recipients.

ASCO Guidelines Assistant is an interactive AI tool developed by ASCO and Google Cloud. The tool allows oncologists to quickly search and use ASCO Guidelines through a simple, intuitive chat.

Conquer Cancer®, the ASCO Foundation and Pfizer External Research & Grants are collaborating to offer a Quality Improvement grant funding opportunity to improve the patient experience in bladder ...

Today, President Trump signed an executive order (EO) directing the administration to communicate most-favored-nation (MFN) drug price targets to pharmaceutical manufacturers for sales in the United ...

ASCO is urging lawmakers to maintain America’s research leadership through continued bipartisan support for federal health agencies and the scientists driving daily progress.